1
|
Liang Y, Schettini R, Kern N, Manciocchi L, Izzo I, Spichty M, Bodlenner A, Compain P. Deconstructing Best-in-Class Neoglycoclusters as a Tool for Dissecting Key Multivalent Processes in Glycosidase Inhibition. Chemistry 2024; 30:e202304126. [PMID: 38221894 DOI: 10.1002/chem.202304126] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/11/2023] [Revised: 01/11/2024] [Accepted: 01/12/2024] [Indexed: 01/16/2024]
Abstract
Multivalency represents an appealing option to modulate selectivity in enzyme inhibition and transform moderate glycosidase inhibitors into highly potent ones. The rational design of multivalent inhibitors is however challenging because global affinity enhancement relies on several interconnected local mechanistic events, whose relative impact is unknown. So far, the largest multivalent effects ever reported for a non-polymeric glycosidase inhibitor have been obtained with cyclopeptoid-based inhibitors of Jack bean α-mannosidase (JBα-man). Here, we report a structure-activity relationship (SAR) study based on the top-down deconstruction of best-in-class multivalent inhibitors. This approach provides a valuable tool to understand the complex interdependent mechanisms underpinning the inhibitory multivalent effect. Combining SAR experiments, binding stoichiometry assessments, thermodynamic modelling and atomistic simulations allowed us to establish the significant contribution of statistical rebinding mechanisms and the importance of several key parameters, including inhitope accessibility, topological restrictions, and electrostatic interactions. Our findings indicate that strong chelate-binding, resulting from the formation of a cross-linked complex between a multivalent inhibitor and two dimeric JBα-man molecules, is not a sufficient condition to reach high levels of affinity enhancements. The deconstruction approach thus offers unique opportunities to better understand multivalent binding and provides important guidelines for the design of potent and selective multiheaded inhibitors.
Collapse
Affiliation(s)
- Yan Liang
- Laboratoire d'Innovation Moléculaire et Applications (LIMA), University of Strasbourg|University of Haute-Alsace|CNRS (UMR 7042), Equipe de Synthèse Organique et Molécules Bioactives (SYBIO), ECPM, 25 Rue Becquerel, 67087, Strasbourg, France)
| | - Rosaria Schettini
- Dipartimento di Chimica e Biologia "A. Zambelli", Università degli Studi di, Salerno, 84084, Fisciano (Salerno), Italy
| | - Nicolas Kern
- Laboratoire d'Innovation Moléculaire et Applications (LIMA), University of Strasbourg|University of Haute-Alsace|CNRS (UMR 7042), Equipe de Synthèse Organique et Molécules Bioactives (SYBIO), ECPM, 25 Rue Becquerel, 67087, Strasbourg, France)
| | - Luca Manciocchi
- Laboratoire d'Innovation Moléculaire et Applications (LIMA), University of Strasbourg|University of Haute-Alsace|CNRS (UMR 7042)-IRJBD, 3 bis rue Alfred Werner, 68057, Mulhouse Cedex, France
| | - Irene Izzo
- Dipartimento di Chimica e Biologia "A. Zambelli", Università degli Studi di, Salerno, 84084, Fisciano (Salerno), Italy
| | - Martin Spichty
- Laboratoire d'Innovation Moléculaire et Applications (LIMA), University of Strasbourg|University of Haute-Alsace|CNRS (UMR 7042)-IRJBD, 3 bis rue Alfred Werner, 68057, Mulhouse Cedex, France
| | - Anne Bodlenner
- Laboratoire d'Innovation Moléculaire et Applications (LIMA), University of Strasbourg|University of Haute-Alsace|CNRS (UMR 7042), Equipe de Synthèse Organique et Molécules Bioactives (SYBIO), ECPM, 25 Rue Becquerel, 67087, Strasbourg, France)
| | - Philippe Compain
- Laboratoire d'Innovation Moléculaire et Applications (LIMA), University of Strasbourg|University of Haute-Alsace|CNRS (UMR 7042), Equipe de Synthèse Organique et Molécules Bioactives (SYBIO), ECPM, 25 Rue Becquerel, 67087, Strasbourg, France)
| |
Collapse
|
2
|
Vaaland IC, López Ó, Puerta A, Fernandes MX, Padrón JM, Fernández-Bolaños JG, Sydnes MO, Lindbäck E. Investigation of the enantioselectivity of acetylcholinesterase and butyrylcholinesterase upon inhibition by tacrine-iminosugar heterodimers. J Enzyme Inhib Med Chem 2023; 38:349-360. [DOI: 10.1080/14756366.2022.2150762] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/03/2022] Open
Affiliation(s)
- I. Caroline Vaaland
- Department of Chemistry, Bioscience and Environmental Engineering, Faculty of Science and Technology, University of Stavanger, Stavanger, Norway
| | - Óscar López
- Departamento de Química Orgánica, Facultad de Química, Universidad de Sevilla, Seville, Spain
| | - Adrián Puerta
- BioLab, Instituto Universitario de Bio-Orgánica “Antonio González” (IUBO-AG), Universidad de La Laguna, c/Astrofísico Francisco Sánchez, La Laguna, Spain
| | - Miguel X. Fernandes
- BioLab, Instituto Universitario de Bio-Orgánica “Antonio González” (IUBO-AG), Universidad de La Laguna, c/Astrofísico Francisco Sánchez, La Laguna, Spain
| | - José M. Padrón
- BioLab, Instituto Universitario de Bio-Orgánica “Antonio González” (IUBO-AG), Universidad de La Laguna, c/Astrofísico Francisco Sánchez, La Laguna, Spain
| | | | - Magne O. Sydnes
- Department of Chemistry, Bioscience and Environmental Engineering, Faculty of Science and Technology, University of Stavanger, Stavanger, Norway
| | - Emil Lindbäck
- Department of Chemistry, Bioscience and Environmental Engineering, Faculty of Science and Technology, University of Stavanger, Stavanger, Norway
| |
Collapse
|
3
|
Buco F, Matassini C, Vanni C, Clemente F, Paoli P, Carozzini C, Beni A, Cardona F, Goti A, Moya SE, Ortore MG, Andreozzi P, Morrone A, Marradi M. Gold nanoparticles decorated with monosaccharides and sulfated ligands as potential modulators of the lysosomal enzyme N-acetylgalactosamine-6-sulfatase (GALNS). Org Biomol Chem 2023; 21:9362-9371. [PMID: 37975191 DOI: 10.1039/d3ob01466e] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2023]
Abstract
N-Acetylgalactosamine-6-sulfatase (GALNS) is an enzyme whose deficiency is related to the lysosomal storage disease Morquio A. For the development of effective therapeutic approaches against this disease, the design of suitable enzyme enhancers (i.e. pharmacological chaperones) is fundamental. The natural substrates of GALNS are the glycosaminoglycans keratan sulfate and chondroitin 6-sulfate, which mainly display repeating units of sulfated carbohydrates. With a biomimetic approach, gold nanoparticles (AuNPs) decorated with simple monosaccharides, sulfated ligands (homoligand AuNPs), or both monosaccharides and sulfated ligands (mixed-ligand AuNPs) were designed here as multivalent inhibitors of GALNS. Among the homoligand AuNPs, the most effective inhibitors of GALNS activity are the β-D-galactoside-coated AuNPs. In the case of mixed-ligand AuNPs, β-D-galactosides/sulfated ligands do not show better inhibition than the β-D-galactoside-coated AuNPs. However, a synergistic effect is observed for α-D-mannosides in a mixed-ligand coating with sulfated ligands that reduced IC50 by one order of magnitude with respect to the homoligand α-D-mannoside-coated AuNPs. SAXS experiments corroborated the association of GALNS with β-D-galactoside AuNPs. These AuNPs are able to restore the enzyme activity by almost 2-fold after thermal denaturation, indicating a potential chaperoning activity towards GALNS. This information could be exploited for future development of nanomedicines for Morquio A. The recent implications of GALNS in cancer and neuropathic pain make these kinds of multivalent bionanomaterials of great interest towards multiple therapies.
Collapse
Affiliation(s)
- Francesca Buco
- Department of Chemistry 'Ugo Schiff', University of Firenze, via della Lastruccia 13, Sesto Fiorentino, FI, Italy.
| | - Camilla Matassini
- Department of Chemistry 'Ugo Schiff', University of Firenze, via della Lastruccia 13, Sesto Fiorentino, FI, Italy.
| | - Costanza Vanni
- Department of Chemistry 'Ugo Schiff', University of Firenze, via della Lastruccia 13, Sesto Fiorentino, FI, Italy.
| | - Francesca Clemente
- Department of Chemistry 'Ugo Schiff', University of Firenze, via della Lastruccia 13, Sesto Fiorentino, FI, Italy.
| | - Paolo Paoli
- Department of Experimental and Clinical Biomedical Sciences, University of Florence, Viale Morgagni 50, 50134 Firenze, Italy
| | - Cosimo Carozzini
- Department of Chemistry 'Ugo Schiff', University of Firenze, via della Lastruccia 13, Sesto Fiorentino, FI, Italy.
| | - Alice Beni
- Department of Chemistry 'Ugo Schiff', University of Firenze, via della Lastruccia 13, Sesto Fiorentino, FI, Italy.
| | - Francesca Cardona
- Department of Chemistry 'Ugo Schiff', University of Firenze, via della Lastruccia 13, Sesto Fiorentino, FI, Italy.
| | - Andrea Goti
- Department of Chemistry 'Ugo Schiff', University of Firenze, via della Lastruccia 13, Sesto Fiorentino, FI, Italy.
| | - Sergio Enrique Moya
- CIC biomaGUNE, Basque Research and Technology Alliance (BRTA), Paseo Miramon 182 C, Donostia-San Sebastián 20014, Spain
| | - Maria Grazia Ortore
- Department of Life and Environmental Sciences, Marche Polytechnic University, Via Brecce Bianche, Ancona, I-60130, Italy
| | - Patrizia Andreozzi
- Department of Chemistry 'Ugo Schiff', University of Firenze, via della Lastruccia 13, Sesto Fiorentino, FI, Italy.
| | - Amelia Morrone
- Laboratory of Molecular Biology of Neurometabolic Diseases, Meyer Children's Hospital, IRCCS, Viale Pieraccini 24, 50139, Firenze, Italy
- Department of Neurosciences, Psychology, Drug Research and Child Health, University of Florence, Viale Pieraccini 24, 50139 Firenze, Italy
| | - Marco Marradi
- Department of Chemistry 'Ugo Schiff', University of Firenze, via della Lastruccia 13, Sesto Fiorentino, FI, Italy.
| |
Collapse
|
4
|
Wang Y, Xiao J, Meng A, Liu C. Multivalent Pyrrolidine Iminosugars: Synthesis and Biological Relevance. Molecules 2022; 27:molecules27175420. [PMID: 36080188 PMCID: PMC9457877 DOI: 10.3390/molecules27175420] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/22/2022] [Revised: 08/17/2022] [Accepted: 08/21/2022] [Indexed: 11/30/2022] Open
Abstract
Recently, the strategy of multivalency has been widely employed to design glycosidase inhibitors, as glycomimetic clusters often induce marked enzyme inhibition relative to monovalent analogs. Polyhydroxylated pyrrolidines, one of the most studied classes of iminosugars, are an attractive moiety due to their potent and specific inhibition of glycosidases and glycosyltransferases, which are associated with many crucial biological processes. The development of multivalent pyrrolidine derivatives as glycosidase inhibitors has resulted in several promising compounds that stand out. Herein, we comprehensively summarized the different synthetic approaches to the preparation of multivalent pyrrolidine clusters, from total synthesis of divalent iminosugars to complex architectures bearing twelve pyrrolidine motifs. Enzyme inhibitory properties and multivalent effects of these synthesized iminosugars were further discussed, especially for some less studied therapeutically relevant enzymes. We envision that this comprehensive review will help extend the applications of multivalent pyrrolidine iminosugars in future studies.
Collapse
Affiliation(s)
- Yali Wang
- College of Pharmacy, North China University of Science and Technology, Tangshan 063000, China
| | - Jian Xiao
- College of Pharmacy, North China University of Science and Technology, Tangshan 063000, China
| | - Aiguo Meng
- Affiliated Hospital, North China University of Science and Technology, Tangshan 063000, China
| | - Chunyan Liu
- College of Pharmacy, North China University of Science and Technology, Tangshan 063000, China
- Correspondence:
| |
Collapse
|
5
|
GCase Enhancers: A Potential Therapeutic Option for Gaucher Disease and Other Neurological Disorders. Pharmaceuticals (Basel) 2022; 15:ph15070823. [PMID: 35890122 PMCID: PMC9325019 DOI: 10.3390/ph15070823] [Citation(s) in RCA: 8] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/10/2022] [Revised: 06/28/2022] [Accepted: 06/29/2022] [Indexed: 12/07/2022] Open
Abstract
Pharmaceutical chaperones (PCs) are small compounds able to bind and stabilize misfolded proteins, allowing them to recover their native folding and thus their biological activity. In particular, lysosomal storage disorders (LSDs), a class of metabolic disorders due to genetic mutations that result in misfolded lysosomal enzymes, can strongly benefit from the use of PCs able to facilitate their translocation to the lysosomes. This results in a recovery of their catalytic activity. No PC for the GCase enzyme (lysosomal acid-β-glucosidase, or glucocerebrosidase) has reached the market yet, despite the importance of this enzyme not only for Gaucher disease, the most common LSD, but also for neurological disorders, such as Parkinson’s disease. This review aims to describe the efforts made by the scientific community in the last 7 years (since 2015) in order to identify new PCs for the GCase enzyme, which have been mainly identified among glycomimetic-based compounds.
Collapse
|
6
|
Vanni C, Clemente F, Paoli P, Morrone A, Matassini C, Goti A, Cardona F. 3,4,5-Trihydroxypiperidine based multivalent glucocerebrosidase (GCase) enhancers. Chembiochem 2022; 23:e202200077. [PMID: 35322924 PMCID: PMC9400994 DOI: 10.1002/cbic.202200077] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/04/2022] [Revised: 03/21/2022] [Indexed: 11/28/2022]
Abstract
The synthesis of five new multivalent derivatives of a trihydroxypiperidine iminosugar was accomplished through copper catalyzed alkyne‐azide cycloaddition (CuAAC) reaction of an azido ending piperidine and several propargylated scaffolds. The resulting multivalent architectures were assayed as inhibitors of lysosomal GCase, the defective enzyme in Gaucher disease. The multivalent compounds resulted in much more potent inhibitors than a parent monovalent reference compound, thus showing a good multivalent effect. Biological investigation of these compounds as pharmacological chaperones revealed that the trivalent derivative (12) gives a 2‐fold recovery of the GCase activity on Gaucher patient fibroblasts bearing the L444P/L444P mutations responsible for neuropathies. Additionally, a thermal denaturation experiment showed its ability to impart stability to the recombinant enzyme used in therapy.
Collapse
Affiliation(s)
- Costanza Vanni
- University of Florence: Universita degli Studi di Firenze, Department of Chemistry "Ugo Schiff", ITALY
| | - Francesca Clemente
- University of Florence: Universita degli Studi di Firenze, Department of Chemistry "Ugo Schiff", ITALY
| | - Paolo Paoli
- University of Florence: Universita degli Studi di Firenze, Department of Chemistry "Ugo Schiff", ITALY
| | - Amelia Morrone
- University of Florence: Universita degli Studi di Firenze, NEUROFARBA, ITALY
| | - Camilla Matassini
- University of Florence: Universita degli Studi di Firenze, Department of Chemistry "Ugo Schiff", ITALY
| | - Andrea Goti
- University of Florence: Universita degli Studi di Firenze, Department of Chemistry "Ugo Schiff", ITALY
| | - Francesca Cardona
- Università di Firenze, Dipartimento di Chimica, Via della Lastruccia 13, 50019, Sesto Fiorentino, ITALY
| |
Collapse
|
7
|
Discovery of human hexosaminidase inhibitors by in situ screening of a library of mono- and divalent pyrrolidine iminosugars. Bioorg Chem 2022; 120:105650. [DOI: 10.1016/j.bioorg.2022.105650] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/09/2021] [Revised: 01/24/2022] [Accepted: 01/28/2022] [Indexed: 01/10/2023]
|
8
|
Della Sala P, Vanni C, Talotta C, Di Marino L, Matassini C, Goti A, Neri P, Šesták S, Cardona F, Gaeta C. Multivalent resorcinarene clusters decorated with DAB-1 inhitopes: targeting Golgi α-mannosidase from Drosophila melanogaster. Org Chem Front 2021. [DOI: 10.1039/d1qo01048d] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Abstract
Resorcinarene@DAB-1 clusters show a remarkable multivalent effect towards GMIIb over other α-mannosidases, due to a rebinding mechanism: two DAB-1 units of the cluster bind the two Zn-sites of the dimeric protein in an alternate way.
Collapse
Affiliation(s)
- Paolo Della Sala
- Laboratory of Supramolecular Chemistry (SupraLab@UniSa), Dipartimento di Chimica e Biologia “A. Zambelli”, Università di Salerno, Via Giovanni Paolo II 132, I-84984, Fisciano, Italy
| | - Costanza Vanni
- Dipartimento di Chimica “Ugo Schiff”, Università degli Studi di Firenze, via della Lastruccia 3-13, 50019 Sesto Fiorentino, FI, Italy
| | - Carmen Talotta
- Laboratory of Supramolecular Chemistry (SupraLab@UniSa), Dipartimento di Chimica e Biologia “A. Zambelli”, Università di Salerno, Via Giovanni Paolo II 132, I-84984, Fisciano, Italy
| | - Luca Di Marino
- Laboratory of Supramolecular Chemistry (SupraLab@UniSa), Dipartimento di Chimica e Biologia “A. Zambelli”, Università di Salerno, Via Giovanni Paolo II 132, I-84984, Fisciano, Italy
| | - Camilla Matassini
- Dipartimento di Chimica “Ugo Schiff”, Università degli Studi di Firenze, via della Lastruccia 3-13, 50019 Sesto Fiorentino, FI, Italy
- Associated with LENS, via N. Carrara 1, 50019 Sesto Fiorentino, FI, Italy
| | - Andrea Goti
- Dipartimento di Chimica “Ugo Schiff”, Università degli Studi di Firenze, via della Lastruccia 3-13, 50019 Sesto Fiorentino, FI, Italy
- Associated with LENS, via N. Carrara 1, 50019 Sesto Fiorentino, FI, Italy
| | - Placido Neri
- Laboratory of Supramolecular Chemistry (SupraLab@UniSa), Dipartimento di Chimica e Biologia “A. Zambelli”, Università di Salerno, Via Giovanni Paolo II 132, I-84984, Fisciano, Italy
| | - Sergej Šesták
- Institute of Chemistry, Center for Glycomics, Slovak Academy of Sciences, Dubravska cesta 9, 84538, Bratislava, Slovakia
| | - Francesca Cardona
- Dipartimento di Chimica “Ugo Schiff”, Università degli Studi di Firenze, via della Lastruccia 3-13, 50019 Sesto Fiorentino, FI, Italy
- Associated with LENS, via N. Carrara 1, 50019 Sesto Fiorentino, FI, Italy
| | - Carmine Gaeta
- Laboratory of Supramolecular Chemistry (SupraLab@UniSa), Dipartimento di Chimica e Biologia “A. Zambelli”, Università di Salerno, Via Giovanni Paolo II 132, I-84984, Fisciano, Italy
| |
Collapse
|
9
|
Martínez-Bailén M, Carmona AT, Cardona F, Matassini C, Goti A, Kubo M, Kato A, Robina I, Moreno-Vargas AJ. Synthesis of multimeric pyrrolidine iminosugar inhibitors of human β-glucocerebrosidase and α-galactosidase A: First example of a multivalent enzyme activity enhancer for Fabry disease. Eur J Med Chem 2020; 192:112173. [PMID: 32146376 DOI: 10.1016/j.ejmech.2020.112173] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/21/2019] [Revised: 02/12/2020] [Accepted: 02/19/2020] [Indexed: 11/29/2022]
Abstract
The synthesis of a chemical library of multimeric pyrrolidine-based iminosugars by incorporation of three pairs of epimeric pyrrolidine-azides into different alkyne scaffolds via CuAAC is presented. The new multimers were evaluated as inhibitors of two important therapeutic enzymes, human α-galactosidase A (α-Gal A) and lysosomal β-glucocerebrosidase (GCase). Structure-activity relationships were established focusing on the iminosugar inhitope, the valency of the dendron and the linker between the inhitope and the central scaffold. Remarkable is the result obtained in the inhibition of α-Gal A, where one of the nonavalent compounds showed potent inhibition (0.20 μM, competitive inhibition), being a 375-fold more potent inhibitor than the monovalent reference. The potential of the best α-Gal A inhibitors to act as pharmacological chaperones was analyzed by evaluating their ability to increase the activity of this enzyme in R301G fibroblasts from patients with Fabry disease, a genetic disorder related with a reduced activity of α-Gal A. The best enzyme activity enhancement was obtained for the same nonavalent compound, which increased 5.2-fold the activity of the misfolded enzyme at 2.5 μM, what constitutes the first example of a multivalent α-Gal A activity enhancer of potential interest in the treatment of Fabry disease.
Collapse
Affiliation(s)
- Macarena Martínez-Bailén
- Departamento de Química Orgánica, Facultad de Química, Universidad de Sevilla, C/Prof. García González, 1, 41012, Sevilla, Spain
| | - Ana T Carmona
- Departamento de Química Orgánica, Facultad de Química, Universidad de Sevilla, C/Prof. García González, 1, 41012, Sevilla, Spain.
| | - Francesca Cardona
- Dipartimento di Chimica "Ugo Schiff", Università degli Studi di Firenze, Via della Lastruccia 3-13, 50019, Sesto Fiorentino, Firenze, Italy; Consorzio Interuniversitario Nazionale di Ricerca in Metodologie e Processi Innovativi di Sintesi (CINMPIS), 70125, Bari, Italy
| | - Camilla Matassini
- Dipartimento di Chimica "Ugo Schiff", Università degli Studi di Firenze, Via della Lastruccia 3-13, 50019, Sesto Fiorentino, Firenze, Italy
| | - Andrea Goti
- Dipartimento di Chimica "Ugo Schiff", Università degli Studi di Firenze, Via della Lastruccia 3-13, 50019, Sesto Fiorentino, Firenze, Italy; Consorzio Interuniversitario Nazionale di Ricerca in Metodologie e Processi Innovativi di Sintesi (CINMPIS), 70125, Bari, Italy
| | - Moemi Kubo
- Department of Hospital Pharmacy, University of Toyama, Toyama, 930-0194, Japan
| | - Atsushi Kato
- Department of Hospital Pharmacy, University of Toyama, Toyama, 930-0194, Japan
| | - Inmaculada Robina
- Departamento de Química Orgánica, Facultad de Química, Universidad de Sevilla, C/Prof. García González, 1, 41012, Sevilla, Spain
| | - Antonio J Moreno-Vargas
- Departamento de Química Orgánica, Facultad de Química, Universidad de Sevilla, C/Prof. García González, 1, 41012, Sevilla, Spain.
| |
Collapse
|
10
|
Mohamed S, He QQ, Singh AA, Ferro V. Mucopolysaccharidosis type II (Hunter syndrome): Clinical and biochemical aspects of the disease and approaches to its diagnosis and treatment. Adv Carbohydr Chem Biochem 2019; 77:71-117. [PMID: 33004112 DOI: 10.1016/bs.accb.2019.09.001] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
Mucopolysaccharidosis type II (MPS II, Hunter syndrome) is a rare X-linked lysosomal storage disease caused by mutations of the gene encoding the lysosomal enzyme iduronate-2-sulfatase (IDS), the role of which is to hydrolytically remove O-linked sulfates from the two glycosaminoglycans (GAGs) heparan sulfate (HS) and dermatan sulfate (DS). HS and DS are linear, heterogeneous polysaccharides composed of repeating disaccharide subunits of l-iduronic acid (IdoA) or d-glucuronic acid, (1→4)-linked to d-glucosamine (for HS), or (1→3)-linked to 2-acetamido-2-deoxy-d-galactose (N-acetyl-d-galactosamine) (for DS). In healthy cells, IDS cleaves the sulfo group found at the C-2 position of terminal non-reducing end IdoA residues in HS and DS. The loss of IDS enzyme activity leads to progressive lysosomal storage of HS and DS in tissues and organs such as the brain, liver, spleen, heart, bone, joints and airways. Consequently, this leads to the phenotypic features characteristic of the disease. This review provides an overview of the disease profile and clinical manifestation, with a particular focus on the biochemical basis of the disease and chemical approaches to the development of new diagnostics, as well as discussing current treatment options and emerging new therapies.
Collapse
Affiliation(s)
- Shifaza Mohamed
- School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, QLD, Australia
| | - Qi Qi He
- School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, QLD, Australia
| | - Arti A Singh
- School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, QLD, Australia
| | - Vito Ferro
- School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, QLD, Australia.
| |
Collapse
|
11
|
Matassini C, D'Adamio G, Vanni C, Goti A, Cardona F. Studies for the Multimerization of DAB-1-Based Iminosugars through Iteration of the Nitrone Cycloaddition/Ring-Opening/Allylation Sequence. European J Org Chem 2019. [DOI: 10.1002/ejoc.201900823] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Affiliation(s)
- Camilla Matassini
- Department of Chemistry “Ugo Schiff”; University of Florence; Via della Lastruccia 3-13 50019 Sesto Fiorentino (FI) Italy
| | - Giampiero D'Adamio
- Department of Chemistry “Ugo Schiff”; University of Florence; Via della Lastruccia 3-13 50019 Sesto Fiorentino (FI) Italy
| | - Costanza Vanni
- Department of Chemistry “Ugo Schiff”; University of Florence; Via della Lastruccia 3-13 50019 Sesto Fiorentino (FI) Italy
| | - Andrea Goti
- Department of Chemistry “Ugo Schiff”; University of Florence; Via della Lastruccia 3-13 50019 Sesto Fiorentino (FI) Italy
- Associated with Consorzio Interuniversitatio Nazionale di ricerca in Metodologie e Processi Innovativi di Sintesi (CINMPIS); Università di Bari; 70125 Bari Italy
| | - Francesca Cardona
- Department of Chemistry “Ugo Schiff”; University of Florence; Via della Lastruccia 3-13 50019 Sesto Fiorentino (FI) Italy
- Associated with Consorzio Interuniversitatio Nazionale di ricerca in Metodologie e Processi Innovativi di Sintesi (CINMPIS); Università di Bari; 70125 Bari Italy
- Associated with LENS; via N. Carrara 1 50019 Sesto Fiorentino, FI Italy
| |
Collapse
|
12
|
Structural basis of the inhibition of GH1 β-glucosidases by multivalent pyrrolidine iminosugars. Bioorg Chem 2019; 89:103026. [DOI: 10.1016/j.bioorg.2019.103026] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/02/2019] [Revised: 05/24/2019] [Accepted: 05/30/2019] [Indexed: 12/11/2022]
|
13
|
Compain P. Multivalent Effect in Glycosidase Inhibition: The End of the Beginning. CHEM REC 2019; 20:10-22. [PMID: 30993894 DOI: 10.1002/tcr.201900004] [Citation(s) in RCA: 34] [Impact Index Per Article: 6.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/23/2019] [Revised: 03/15/2019] [Indexed: 12/21/2022]
Abstract
Glycosidases are ubiquitous enzymes involved in a diversity of key biological processes such as energy uptake or cell wall degradation. The design of specific glycosidase inhibitors has been therefore the subject of intense research efforts in academia and pharmaceutical industry. However, until recently, the study of the impact of multivalency on glycosidase inhibition was almost completely neglected. The following account will review our ten year journey on the design of multivalent glycomimetics within our research group, from the discovery of the first strong multivalent effect in glycosidase inhibition to the high-resolution crystal structures of Jack bean α-mannosidase in complex with the multimeric inhibitor displaying the largest binding enhancements reported so far.
Collapse
Affiliation(s)
- Philippe Compain
- Laboratoire d'Innovation Moléculaire et Applications (LIMA), Univ. de Strasbourg, Univ. de Haute-Alsace, CNRS (UMR 7042), Equipe de Synthèse Organique et Molécules Bioactives (SYBIO), ECPM, 25 Rue Becquerel, 67000, Strasbourg, France
| |
Collapse
|
14
|
Ferhati X, Matassini C, Fabbrini MG, Goti A, Morrone A, Cardona F, Moreno-Vargas AJ, Paoli P. Dual targeting of PTP1B and glucosidases with new bifunctional iminosugar inhibitors to address type 2 diabetes. Bioorg Chem 2019; 87:534-549. [PMID: 30928876 DOI: 10.1016/j.bioorg.2019.03.053] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/15/2019] [Revised: 03/04/2019] [Accepted: 03/18/2019] [Indexed: 10/27/2022]
Abstract
The diffusion of type 2 diabetes (T2D) throughout the world represents one of the most important health problems of this century. Patients suffering from this disease can currently be treated with numerous oral anti-hyperglycaemic drugs, but none is capable of reproducing the physiological action of insulin and, in several cases, they induce severe side effects. Developing new anti-diabetic drugs remains one of the most urgent challenges of the pharmaceutical industry. Multi-target drugs could offer new therapeutic opportunities for the treatment of T2D, and the reported data on type 2 diabetic mice models indicate that these drugs could be more effective and have fewer side effects than mono-target drugs. α-Glucosidases and Protein Tyrosine Phosphatase 1B (PTP1B) are considered important targets for the treatment of T2D: the first digest oligo- and disaccharides in the gut, while the latter regulates the insulin-signaling pathway. With the aim of generating new drugs able to target both enzymes, we synthesized a series of bifunctional compounds bearing both a nitro aromatic group and an iminosugar moiety. The results of tests carried out both in vitro and in a cell-based model, show that these bifunctional compounds maintain activity on both target enzymes and, more importantly, show a good insulin-mimetic activity, increasing phosphorylation levels of Akt in the absence of insulin stimulation. These compounds could be used to develop a new generation of anti-hyperglycemic drugs useful for the treatment of patients affected by T2D.
Collapse
Affiliation(s)
- Xhenti Ferhati
- Department of Chemistry 'Ugo Schiff', University of Firenze, via della Lastruccia 3-13, Sesto Fiorentino, (FI), Italy
| | - Camilla Matassini
- Department of Chemistry 'Ugo Schiff', University of Firenze, via della Lastruccia 3-13, Sesto Fiorentino, (FI), Italy
| | - Maria Giulia Fabbrini
- Department of Chemistry 'Ugo Schiff', University of Firenze, via della Lastruccia 3-13, Sesto Fiorentino, (FI), Italy
| | - Andrea Goti
- Department of Chemistry 'Ugo Schiff', University of Firenze, via della Lastruccia 3-13, Sesto Fiorentino, (FI), Italy; Associated with Consorzio Interuniversitario Nazionale di ricerca in Metodologie e Processi Innovativi di Sintesi (CINMPIS), Italy
| | - Amelia Morrone
- Paediatric Neurology Unit and Laboratories, Neuroscience Department, Meyer Children's Hospital, and Department of Neurosciences, Pharmacology and Child Health. University of Florence, Viale Pieraccini n. 24, 50139 Firenze, Italy
| | - Francesca Cardona
- Department of Chemistry 'Ugo Schiff', University of Firenze, via della Lastruccia 3-13, Sesto Fiorentino, (FI), Italy; Associated with Consorzio Interuniversitario Nazionale di ricerca in Metodologie e Processi Innovativi di Sintesi (CINMPIS), Italy.
| | - Antonio J Moreno-Vargas
- Departamento de Química Orgánica, Facultad de Química, Universidad de Sevilla, n/Prof. García González 1, E-41012 Sevilla, Spain
| | - Paolo Paoli
- Department of Experimental and Clinical Biomedical Sciences, University of Florence, Viale Morgagni 50, 50134 Florence, Italy.
| |
Collapse
|
15
|
Probing the Influence of Linker Length and Flexibility in the Design and Synthesis of New Trehalase Inhibitors. Molecules 2018; 23:molecules23020436. [PMID: 29462919 PMCID: PMC6017881 DOI: 10.3390/molecules23020436] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/30/2018] [Revised: 02/12/2018] [Accepted: 02/14/2018] [Indexed: 12/22/2022] Open
Abstract
This work aims to synthesize new trehalase inhibitors selective towards the insect trehalase versus the porcine trehalase, in view of their application as potentially non-toxic insecticides and fungicides. The synthesis of a new pseudodisaccharide mimetic 8, by means of a stereoselective α-glucosylation of the key pyrrolizidine intermediate 13, was accomplished. The activity of compound 8 as trehalase inhibitor towards C. riparius trehalase was evaluated and the results showed that 8 was active in the μM range and showed a good selectivity towards the insect trehalase. To reduce the overall number of synthetic steps, simpler and more flexible disaccharide mimetics 9–11 bearing a pyrrolidine nucleus instead of the pyrrolizidine core were synthesized. The biological data showed the key role of the linker chain’s length in inducing inhibitory properties, since only compounds 9 (α,β-mixture), bearing a two-carbon atom linker chain, maintained activity as trehalase inhibitors. A proper change in the glucosyl donor-protecting groups allowed the stereoselective synthesis of the β-glucoside 9β, which was active in the low micromolar range (IC50 = 0.78 μM) and 12-fold more potent (and more selective) than 9α towards the insect trehalase.
Collapse
|
16
|
Matassini C, Vanni C, Goti A, Morrone A, Marradi M, Cardona F. Multimerization of DAB-1 onto Au GNPs affords new potent and selective N-acetylgalactosamine-6-sulfatase (GALNS) inhibitors. Org Biomol Chem 2018; 16:8604-8612. [DOI: 10.1039/c8ob02587h] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Abstract
Gold glyconanoparticles (Au GNPs) decorated with the natural iminosugar DAB-1 at different densities are reported.
Collapse
Affiliation(s)
- C. Matassini
- Department of Chemistry ‘Ugo Schiff’
- University of Firenze
- Sesto Fiorentino
- Italy
- Associated with CNR-INO and LENS
| | - C. Vanni
- Department of Chemistry ‘Ugo Schiff’
- University of Firenze
- Sesto Fiorentino
- Italy
| | - A. Goti
- Department of Chemistry ‘Ugo Schiff’
- University of Firenze
- Sesto Fiorentino
- Italy
- Associated with CNR-INO and LENS
| | - A. Morrone
- Paediatric Neurology Unit and Laboratories
- Neuroscience Department
- Meyer Children's Hospital
- and Department of Neurosciences
- Pharmacology and Child Health
| | - M. Marradi
- CIC biomaGUNE and CIBER-BBN
- Donostia-San Sebastián
- Spain
| | - F. Cardona
- Department of Chemistry ‘Ugo Schiff’
- University of Firenze
- Sesto Fiorentino
- Italy
- Associated with CNR-INO and LENS
| |
Collapse
|
17
|
Mirabella S, D'Adamio G, Matassini C, Goti A, Delgado S, Gimeno A, Robina I, Moreno-Vargas AJ, Šesták S, Jiménez-Barbero J, Cardona F. Mechanistic Insight into the Binding of Multivalent Pyrrolidines to α-Mannosidases. Chemistry 2017; 23:14585-14596. [DOI: 10.1002/chem.201703011] [Citation(s) in RCA: 25] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/30/2017] [Indexed: 11/11/2022]
Affiliation(s)
- Stefania Mirabella
- Dipartimento di Chimica “Ugo Schiff”; Università degli Studi di Firenze; Via della Lastruccia 3-13 50019 Sesto Fiorentino (FI) Italy
- CIC bioGUNE; Bizkaia Science and Technology Park; Building 801A 48160 Derio Spain
| | - Giampiero D'Adamio
- Dipartimento di Chimica “Ugo Schiff”; Università degli Studi di Firenze; Via della Lastruccia 3-13 50019 Sesto Fiorentino (FI) Italy
| | - Camilla Matassini
- Dipartimento di Chimica “Ugo Schiff”; Università degli Studi di Firenze; Via della Lastruccia 3-13 50019 Sesto Fiorentino (FI) Italy
- CNR-INO; Via N. Carrara 1 Sesto Fiorentino (FI) Italy
| | - Andrea Goti
- Dipartimento di Chimica “Ugo Schiff”; Università degli Studi di Firenze; Via della Lastruccia 3-13 50019 Sesto Fiorentino (FI) Italy
- CNR-INO; Via N. Carrara 1 Sesto Fiorentino (FI) Italy
| | - Sandra Delgado
- CIC bioGUNE; Bizkaia Science and Technology Park; Building 801A 48160 Derio Spain
| | - Ana Gimeno
- CIC bioGUNE; Bizkaia Science and Technology Park; Building 801A 48160 Derio Spain
| | - Inmaculada Robina
- Departamento de Química Orgánica; Facultad de Química; Universidad de Sevilla; c/Prof. García González 1 41012 Sevilla Spain
| | - Antonio J. Moreno-Vargas
- Departamento de Química Orgánica; Facultad de Química; Universidad de Sevilla; c/Prof. García González 1 41012 Sevilla Spain
| | - Sergej Šesták
- Institute of Chemistry; Center for Glycomics; Slovak Academy of Sciences; Dúbravska cesta 9 84538 Bratislava Slovakia
| | - Jesús Jiménez-Barbero
- CIC bioGUNE; Bizkaia Science and Technology Park; Building 801A 48160 Derio Spain
- Ikerbasque; Basque Foundation for Science; Maria Diaz de Haro 5 48005 Bilbao Spain
- Departament Organic Chemistry II; EHU-UPV; 48040 Leioa Spain
| | - Francesca Cardona
- Dipartimento di Chimica “Ugo Schiff”; Università degli Studi di Firenze; Via della Lastruccia 3-13 50019 Sesto Fiorentino (FI) Italy
- CNR-INO; Via N. Carrara 1 Sesto Fiorentino (FI) Italy
| |
Collapse
|
18
|
Matassini C, Parmeggiani C, Cardona F, Goti A. Are enzymes sensitive to the multivalent effect? Emerging evidence with glycosidases. Tetrahedron Lett 2016. [DOI: 10.1016/j.tetlet.2016.10.080] [Citation(s) in RCA: 44] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/19/2023]
|